MedTrace Logo

Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19

NCT04505709 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-08-10

No results posted yet for this study

Summary

The STOP-Coronavirus project is an integrated and multidisciplinary study that aims to analyze the impact that various factors have on the evolution and prognosis of the current COVID-19. Clinical presentation, immunological markers, therapeutic strategies, host and virus genomics, and bioethical considerations will be analyzed with a prospective multicenter cohort of patients with a diagnosis of COVID-19.

Conditions

  • Covid19

Sponsors & Collaborators

  • Hospital Universitario 12 de Octubre

    collaborator OTHER

  • Fundacion Investigacion Biomedica Hospital 12 de Octubre

    collaborator UNKNOWN

  • Hospital Universitario Fundación Jiménez Díaz

    collaborator OTHER

  • Hospital Universitario Infanta Elena

    collaborator UNKNOWN

  • Hospital Universitario Virgen de la Arrixaca

    collaborator OTHER

  • Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca

    collaborator OTHER

  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

    lead OTHER

Eligibility

Min Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2021-08-01
Completion
2021-08-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04505709 on ClinicalTrials.gov